Bladder Cancer Trials

Benefits of clinical trials research - bladder cancer

This large-scale, randomised trial will determine the effects of adding mitomycin to BCG on cure rates, survival, side effects, and quality of life.

This study looks at whether Nab-Paclitaxel improves survival and is less toxic with improved quality of life compared with Paclitaxel.

This trial is aimed at managing bladder cancer that has spread into the wall of the bladder with the addition of pembrolizumab to the standard therapy of chemotherapy and radiation therapy.

© ANZUP 2017. All rights reserved.